InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Wolf Myles, Director. Director active across 1 company, notably Akebia Therapeutics, Inc.. Cumulatively, 6 reports have been logged. History available since 2 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wolf Myles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
35,700 sharesCommon StockSEC:0001808317-26-000001:0
35,700 shares0Common StockSEC:0001562180-25-004722:0
30,000 shares0Common StockSEC:0001562180-24-004910:0
30,000 shares0Common StockSEC:0001562180-23-004957:0
13,700 shares0Common StockSEC:0001562180-22-004978:0
13,700 shares0Common StockSEC:0001562180-21-004031:0
6 of 6 declarations
About Wolf Myles
Myles Wolf is a Board Member at Akebia Therapeutics, Inc. He contributes to the governance of the company by participating in strategic decisions and providing his expertise to the board.
